The objective of the MRFF 2020 COVID-19 Vaccine Candidate Research Grant Opportunity is to accelerate the development of promising COVID-19 prophylactic vaccine candidates for which research and development is already underway. The prophylactic vaccine must be intended to induce active long-term immunity against COVID-19.

The vaccine candidate must have progressed beyond early or “developmental” stage research to pre-clinical or clinical investigation, and applicants must have already generated proof-of-concept data that supports pre-clinical or clinical development of the vaccine candidate. Applicants must also demonstrate access to critical resources necessary to complete the project in the stipulated timeframes.

The intended outcome of the research is to support rapid development of a safe and effective COVID-19 prophylactic (disease-preventing) vaccine, which induces active long-term immunity, within the next 12-18 months.

This Grant Opportunity will consist of a maximum of three Rounds. A round will comprise two application steps: expression of interest and full applications.

Applications must address the desired outcomes described in section 1.3 of the grant guidelines.

This opportunity is supported by the Medical Research Future Fund (MRFF).

Applications will only be accepted from NHMRC approved Administering Institutions. A list of NHMRC approved Administering Institutions is available on GrantConnect and on the NHMRC website:

Applications must satisfy all the requirements set out in the Medical Research Future Fund (MRFF) Coronavirus Research Response: 2020 Respiratory Medicine Clinical Trials Research on COVID-19 Grant Opportunity Guideline

Total Amount Available (AUD):


Estimated Grant Value (AUD):

From – to $3,000,000.00


Scroll to Top